Pheochromocytoma.
The only definitive therapy for patients with pheochromocytoma is surgical resection [1,2**]. Advances in preoperative medical management of hypertension/hypovolemia and improved intraoperative anesthetic care have reduced the operative mortality rate for pheochromocytoma to less than 5% in most series. In addition, accurate preoperative localization studies have eliminated the need for extensive exploratory laparotomy. Focused approach and laparoscopic resection have become the new "gold standard," with a reduced morbidity [4**]. Large or locally invasive pheochromocytomas may still require open resection.
Eigelberger
M S
MS
Department of Surgery, University of California, San Francisco/Mt. Zion Medical Center, University of California, Campus Box 1674, San Francisco, CA 94143-1674, USA.
Duh
Q Y
QY
D019797:3-Iodobenzylguanidine / Q000627:therapeutic use; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy; D000313:Adrenal Medulla / Q000378:metabolism; D000315:Adrenalectomy / Q000379:methods; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002395:Catecholamines / Q000378:metabolism / Q000652:urine; D003952:Diagnostic Imaging; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D010535:Laparoscopy; D008676:Metanephrine / Q000652:urine; D009386:Neoplastic Syndromes, Hereditary; D010166:Palliative Care; D010673:Pheochromocytoma / Q000150:complications / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy; D013610:Tachycardia / Q000188:drug therapy / Q000209:etiology
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D002395:Catecholamines; D019797:3-Iodobenzylguanidine; D008676:Metanephrine